Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study
There were no significant differences in GI- or CV-related complications between patients treated with tegoprazan and those treated with PPIs.
Authors
- Jongha Park (ORCID: https://orcid.org/0000-0002-1461-9483)
- J. H. Choi
- Seung Ha Park (ORCID: https://orcid.org/0000-0002-5950-2713)
- Yong Eun Park (ORCID: https://orcid.org/0000-0003-4274-8204)
- Nae-Yun Heo
- Jino Park (ORCID: https://orcid.org/0000-0002-3497-8782)
- Tae Oh Kim
- Jin Lee
Institutions
- Inje University Haeundae Paik Hospital (KR)
Publication Details
- Journal
- The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Published
- 2026-01-20
- DOI
- https://doi.org/10.7704/kjhugr.2025.0065
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Inje University